Lopinavir (200 mg)/Ritonavir (50 mg) drug sources and characteristics.

<p>Lopinavir (200 mg)/Ritonavir (50 mg) drug sources and characteristics.</p

Sampled drugs, ordered by site ID.

<p>Sampled drugs, ordered by site ID.</p

Tenofovir (300 mg) drug sources and characteristics.

<p>Tenofovir (300 mg) drug sources and characteristics.</p

Geographic location of sampling sites in Thailand and Vietnam.

<p>Geographic location of sampling sites in Thailand and Vietnam.</p

Descriptive statistics of drug content, uniformity of mass and dissolution tests.

<p>Descriptive statistics of drug content, uniformity of mass and dissolution tests.</p

Percent of label amount of each sampled ARV, by sampling site.

<p>Percent of label amount of each sampled ARV, by sampling site.</p

Efavirenz (600 mg) drug sources and characteristics.

<p>Efavirenz (600 mg) drug sources and characteristics.</p

10(Framingham Equation) categories by treatment arm at baseline and 48 weeks.

<p>10(Framingham Equation) categories by treatment arm at baseline and 48 weeks.</p

Baseline predictors of change in limb fat mass over 48

<p>Baseline predictors of change in limb fat mass over 48</p

Patient disposition of SECONDLINE body composition sub-study.

<p>Patient disposition of SECONDLINE body composition sub-study.</p